Tagged: Patents Toggle Comment Threads | Keyboard Shortcuts

  • Goyal 20:18 on Monday, March 19, 2007 Permalink | Reply
    Tags: Patents   

    Good Weekend 

    Had a great weekend.

    1. Watched 300 – I would call it a decent movie. Watchable. Nothing great. The movie has awesome graphics and some midblowing sequences, like the one where a Spartan kills a Rhino, but what the movie lacks is the ability to get the audience involved in the movie. The movie has lots of blood and gore but at no moment do you find yourself squirming at it. The movie shows underdogs fighting against all odds, but at no moment do you find yourself rooting for it.
    2. Installed Windows on the home PC. Also installed Ubuntu on one of the partitions. Seems that I remember some Linux after all.
    3. Watched the Australian GP. Kimi kicked real ass in his first race with Ferrari. Gonna be fun filled season it seems. Also, Lewis Hamilton drove with purpose and seems like he is gonna give Alonso one heck of a fight. Kubica and Rosberg also drove nicely.
    4. Had loads of fun with Sam, TK, Appu, Pari, Bansal and Sachin. One of the fun filled weekends you always look forward to.

    On a separate note the DL101 I had registered for on WIPO Academy sent me the certificate for successful completion of the course. Very cool I must say. Will post a scanned copy very soon.

    Last, but not the least, Inzy has retired. The lazy elegance will not be seen in One day cricket any more after the World Cup. You will be missed.

    Advertisement
     
    • Ojas 10:21 on Tuesday, March 20, 2007 Permalink | Reply

      Congrats on DL101.. I just kept getting reminder emails 😐
      Haven’t a slightest idea that the new F1 season’s started. Shall catch up with it this time.

  • Goyal 11:33 on Thursday, December 14, 2006 Permalink | Reply
    Tags: , Google Patents, , Mashup, Patents, Search Engine, USPTO   

    Google’s Patent Search 

    The inevitable has happened. Google has finally launched a patent search engine. You can check it out at http://www.google.com/patents

    For long I had wished that Google gives a better patent search option, and it has finally happened. Complete with advanced search options including assignee, inventor, IPC classes, and date limitations it is gonna be one heck of a tool for prior art search. I hope it does normal language search more effectively than concept search on PatentCafe.

    Though the jurisdiction coverage is currently limited to granted US patents only, I am sure it would not be long before it adds other major Patent Offices like EPO and WIPO to it and published applications/pre-grant publications.

    I sure see some competition for us in the future and also for IP service providers like Thomson Scientific.

    What I now want to see is a mashup which combines Google Patent Search and Google Spreadsheets & Docs. That would be so much fun!!

    PS: The official post is at http://googleblog.blogspot.com/2006/12/now-you-can-search-for-us-patents.html.

     
  • Goyal 20:31 on Tuesday, December 5, 2006 Permalink | Reply
    Tags: Drug, Lipitor, Patents, Pfizer   

    Lipitor Sucessor Fails! 

    Pfizer, world’s largest drug maker, got hammered badly in the NYSE on Monday following the disclosure that it had pulled the plug on its “to-be” blockbuster drug, torcetrapib. The stock lost 11% of its market value and wiped out USD 21 bn off its market cap.

    Though some might consider this as excessive, this just goes to show what one drug can do to a company’s fortune. Pfizer banks on Lipitor for almost a quarter of its annual USD 51 bn sales and a higher percentage of its profits. With Lipitor patent coverage expiring in 2011 (thanks to Ranbaxy), torcetrapib was supposed to take its place and drive the company’s growth and profits. Pfizer had spent over a billion USD on the development of the drug and pulling it out at the last stage of development has prompted Moody to reconsider the downgrading of Pfizer’s rating from the present Aaa.

    Also interesting is the increase in the share prices of its competitors, namely, Roche and Astra Zeneca. Many also expect that this failure might change the way big companies focus on blockbuster drugs to drive both topline and bottomline growth.

     
  • Goyal 3:10 on Wednesday, September 13, 2006 Permalink | Reply
    Tags: , Patents   

    Patents 2.0? 

    Only recently the USPTO suggested a peer review mechanism to ensure that bad patents are minimized. Wikipatents, launched on August 28th, aims to contribute to “the US patent system by commenting on issued patents and, soon, pending patent applications.” This comes on the heels of the IBM, Red Hat, Microsoft and Hewlett-Packard backed Community Patent Review plan of the New York Law School scheduled for a debut early next year.

    A Web 2.0 website, complete with AJAX and Digg options, Wikipatents, provides you with entire patent data in HTML/PDF format and allows a registered user to write a title and abstract in a layman’s language. It also allows users to vote on cited references, add comments to existing ones and add new references. A new concept here is the market review which allows a user to estimate parameters like marketing and licensing potential of a patent.

    While I am supportive of the entire exercise, I have my doubts about the efficacy of the system. First of all patents hardly ever directly impact the public and it is mostly big companies (holders of huge IP portfolio themselves) who are nowadays being sued left, right and center by the so-called patent trolls that are more worried about bad patents. I mean IBM and Microsoft themselves hold patent portfolios greater than many countries. I find no reason for people to sympathize with them.

    Second, patent laws are so unclear and confusing that not many people know about them. Outside the patent attorneys I think hardly anyone would know their priority dates from filing dates.

    Third, it is very difficult to gather relevant prior art without a very good understanding of the technology domain and access to proper patent and non-patent databases.

    And lastly, relevant prior art is not easily available and finding it requires a lot of man hours and huge effort, else the patent examiners would have found them. Further, patent valuation is a largely inexact science at the best and requires huge amount of experience and prior research to arrive at any value for a patent.

    So while it would be nice to get a community review of a patent, I for one would take any information provided with a pinch of salt, or combinations thereof.

    PS: Also posted on Desicritics here.

     
c
Compose new post
j
Next post/Next comment
k
Previous post/Previous comment
r
Reply
e
Edit
o
Show/Hide comments
t
Go to top
l
Go to login
h
Show/Hide help
shift + esc
Cancel